Literature DB >> 8955144

Glutathione levels and sensitivity to apoptosis are regulated by changes in transaldolase expression.

K Banki1, E Hutter, E Colombo, N J Gonchoroff, A Perl.   

Abstract

Transaldolase (TAL) is a key enzyme of the reversible nonoxidative branch of the pentose phosphate pathway (PPP) that is responsible for the generation of NADPH to maintain glutathione at a reduced state (GSH) and, thus, to protect cellular integrity from reactive oxygen intermediates (ROIs). Formation of ROIs have been implicated in certain types of apoptotic cell death. To evaluate the role of TAL in this process, Jurkat human T cells were permanently transfected with TAL expression vectors oriented in the sense or antisense direction. Overexpression of TAL resulted in a decrease in glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase activities and NADPH and GSH levels and rendered these cells highly susceptible to apoptosis induced by serum deprivation, hydrogen peroxide, nitric oxide, tumor necrosis factor-alpha, and anti-Fas monoclonal antibody. In addition, reduced levels of TAL resulted in increased glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase activities and increased GSH levels with inhibition of apoptosis in all five model systems. The effect of TAL expression on susceptibility to apoptosis through regulating the PPP and GSH production is consistent with an involvement of ROIs in each pathway tested. Production of ROIs in Fas-mediated cell death was further substantiated by measurement of intracellular ROI production with oxidation-sensitive fluorescent probes, by the protective effects of GSH precursor, N-acetyl cysteine, free radical spin traps 5,5-dimethyl-1-pyrroline-1-oxide and 3,3,5,5-tetramethyl-1-pyrroline-1-oxide, the antioxidants desferrioxamine, nordihydroguaiaretic acid, and Amytal, and by the enhancing effects of GSH depletion with buthionine sulfoximine. The results provide definitive evidence that TAL has a role in regulating the balance between the two branches of PPP and its overall output as measured by GSH production and thus influences sensitivity to cell death signals.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8955144     DOI: 10.1074/jbc.271.51.32994

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

Review 1.  Mechanisms of viral pathogenesis in rheumatic disease.

Authors:  A Perl
Journal:  Ann Rheum Dis       Date:  1999-08       Impact factor: 19.103

Review 2.  The biochemistry, metabolism and inherited defects of the pentose phosphate pathway: a review.

Authors:  M M C Wamelink; E A Struys; C Jakobs
Journal:  J Inherit Metab Dis       Date:  2008-11-08       Impact factor: 4.982

Review 3.  Oxidative stress, inflammation and carcinogenesis are controlled through the pentose phosphate pathway by transaldolase.

Authors:  Andras Perl; Robert Hanczko; Tiffany Telarico; Zachary Oaks; Steve Landas
Journal:  Trends Mol Med       Date:  2011-03-02       Impact factor: 11.951

4.  Deciphering glycomics and neuroproteomic alterations in experimental traumatic brain injury: Comparative analysis of aspirin and clopidogrel treatment.

Authors:  Hussein Abou-Abbass; Hisham Bahmad; Hadi Abou-El-Hassan; Rui Zhu; Shiyue Zhou; Xue Dong; Eva Hamade; Khalil Mallah; Abir Zebian; Naify Ramadan; Stefania Mondello; Jawad Fares; Youssef Comair; Samir Atweh; Hala Darwish; Kazem Zibara; Yehia Mechref; Firas Kobeissy
Journal:  Electrophoresis       Date:  2016-03-29       Impact factor: 3.535

5.  Uncoupling protein 2 has protective function during experimental autoimmune encephalomyelitis.

Authors:  Susanne Vogler; Jens Pahnke; Sophie Rousset; Daniel Ricquier; Holger Moch; Bruno Miroux; Saleh M Ibrahim
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

Review 6.  Systems biology of lupus: mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatment.

Authors:  Andras Perl
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

7.  Deletion of Ser-171 causes inactivation, proteasome-mediated degradation and complete deficiency of human transaldolase.

Authors:  Craig E Grossman; Brian Niland; Christina Stancato; Nanda M Verhoeven; Marjo S Van Der Knaap; Cornelis Jakobs; Lawrence M Brown; Sandor Vajda; Katalin Banki; Andras Perl
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

8.  Transaldolase deficiency: report of 12 new cases and further delineation of the phenotype.

Authors:  Wafaa Eyaid; Talal Al Harbi; Shamsa Anazi; Mirjam M C Wamelink; Cornelis Jakobs; Mohammad Al Salammah; Mohammed Al Balwi; Majid Alfadhel; Fowzan S Alkuraya
Journal:  J Inherit Metab Dis       Date:  2013-01-12       Impact factor: 4.982

9.  Proteome changes in human bronchoalveolar cells following styrene exposure indicate involvement of oxidative stress in the molecular-response mechanism.

Authors:  Nora Mörbt; Iljana Mögel; Stefan Kalkhof; Ralph Feltens; Carmen Röder-Stolinski; Jiang Zheng; Carsten Vogt; Irina Lehmann; Martin von Bergen
Journal:  Proteomics       Date:  2009-11       Impact factor: 3.984

10.  Phasing of muscle gene expression with fasting-induced recovery growth in Atlantic salmon.

Authors:  Neil I Bower; Richard G Taylor; Ian A Johnston
Journal:  Front Zool       Date:  2009-08-24       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.